{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T02:23:12Z","timestamp":1766197392374,"version":"3.46.0"},"reference-count":58,"publisher":"Royal College of General Practitioners","issue":"760","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"accepted":{"date-parts":[[2025,6,8]]},"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Timely initiation of insulin is critical to prevent long-term complications associated with poor glycaemic control. A better understanding of the factors influencing insulin initiation is essential to guide person-centred treatment and reduce disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To examine factors associated with insulin initiation within 5 years after starting metformin in adults with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>Cohort study using ELAN primary care data linked to Statistics Netherlands registry data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Adults aged 40\u201379 years with T2DM who initiated metformin between 2007 and 2023 were included. Fine and Gray competing risk analysis was used to assess time to insulin initiation while accounting for death. Covariates measured within 6 months of metformin initiation included age, sex, smoking status, body mass index (BMI), systolic blood pressure, country of origin, household income, household support, glycosylated haemoglobin (HbA\n                      <jats:sup>1c<\/jats:sup>\n                      ), estimated glomerular filtration rate (eGFR), total cholesterol, and high-density lipoprotein (HDL) cholesterol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 24 360 individuals with T2DM on metformin, 2326 (10%) initiated insulin within 5 years. Compared with individuals of Dutch origin, insulin initiation was less likely among people with Surinamese (subdistribution hazard ratio [SHR] 0.62, 95% confidence interval [CI] = 0.45 to 0.79), Turkish (SHR 0.61, 95% CI = 0.30 to 0.91), or other backgrounds other than Dutch (SHR 0.76, 95% CI = 0.61 to 0.90). Higher HbA1c increased the likelihood of insulin initiation (SHR 1.54 per 13 mmol\/mol, 95% CI = 1.51 to 1.57). Factors associated with a lower probability of insulin initiation included higher household income (SHR 0.94 per 28% increase, 95% CI = 0.89 to 0.98), overweight or obesity versus having a healthy BMI, older age, higher eGFR, higher HDL, and later calendar year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Besides biological factors, backgrounds other than Dutch and higher household income are linked to a lower probability of initiating insulin therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3399\/bjgp.2024.0693","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:35:15Z","timestamp":1756823715000},"page":"e749-e758","source":"Crossref","is-referenced-by-count":1,"title":["Sociodemographic and biological determinants of insulin initiation in type 2 diabetes: a cohort study using routinely collected primary care data"],"prefix":"10.3399","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-833X","authenticated-orcid":false,"given":"Sukainah A","family":"Alfaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimke C","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-221X","authenticated-orcid":false,"given":"Marco","family":"Spruit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-6999","authenticated-orcid":false,"given":"Rolf HH","family":"Groenwold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-5122","authenticated-orcid":false,"given":"Dennis O","family":"Mook-Kanamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"2025103018251533000_75.760.e749.1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275"},{"key":"2025103018251533000_75.760.e749.2","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes \u2014 2022","volume":"45 (Suppl 1)","year":"2022","journal-title":"Diabetes Care"},{"issue":"4","key":"2025103018251533000_75.760.e749.3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.therap.2021.10.002","article-title":"Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: a meta-analysis of randomised control-trials","volume":"77","author":"Sun","year":"2022","journal-title":"Therapie"},{"issue":"2","key":"2025103018251533000_75.760.e749.4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00125-017-4473-2","article-title":"Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)","volume":"61","author":"Agrawal","year":"2018","journal-title":"Diabetologia"},{"key":"2025103018251533000_75.760.e749.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05787-2"},{"key":"2025103018251533000_75.760.e749.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0331"},{"key":"2025103018251533000_75.760.e749.7","doi-asserted-by":"publisher","DOI":"10.7326\/m20-0864"},{"key":"2025103018251533000_75.760.e749.8","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0081"},{"key":"2025103018251533000_75.760.e749.9","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-013-0034-y"},{"key":"2025103018251533000_75.760.e749.10","doi-asserted-by":"crossref","first-page":"1366368","DOI":"10.3389\/fendo.2024.1366368","article-title":"Current barriers to initiating insulin therapy in individuals with type 2 diabetes","volume":"15","author":"Gald\u00f3n Sanz-Pastor","year":"2024","journal-title":"Front Endocrinol"},{"issue":"4","key":"2025103018251533000_75.760.e749.11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/dia.2014.0268","article-title":"Current perspectives on psychological insulin resistance: primary care provider and patient views","volume":"17","author":"Krall","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"2025103018251533000_75.760.e749.12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/ijcp.12691","article-title":"Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review","volume":"69","author":"Ng","year":"2015","journal-title":"Int J Clin Pract"},{"key":"2025103018251533000_75.760.e749.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01602.x"},{"key":"2025103018251533000_75.760.e749.14","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6823-9-19","article-title":"The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study","volume":"9","author":"Goodall","year":"2009","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2025103018251533000_75.760.e749.15","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.61","article-title":"Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: an electronic medical record database analysis","volume":"2","author":"Raccah","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"2025103018251533000_75.760.e749.16","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0005"},{"key":"2025103018251533000_75.760.e749.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmph.2022.101178","article-title":"Socioeconomic inequalities in insulin initiation among individuals with type 2 diabetes \u2014 a quasi-experimental nationwide register study","volume":"19","author":"R\u00e4tt\u00f6","year":"2022","journal-title":"SSM Popul Health"},{"key":"2025103018251533000_75.760.e749.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003106"},{"issue":"1","key":"2025103018251533000_75.760.e749.19","first-page":"e1","article-title":"Factors influencing insulin initiation in primary care facilities in cape town, south africa","volume":"65","author":"Mathose","year":"2004","journal-title":"S Afr Fam Pract"},{"issue":"6","key":"2025103018251533000_75.760.e749.20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11606-017-4282-9","article-title":"Predictors of insulin initiation in patients with type 2 diabetes: an analysis of the Look AHEAD randomized trial","volume":"33","author":"Pilla","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2025103018251533000_75.760.e749.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2023.104769","article-title":"The introduction of a data-driven population health management approach in the Netherlands since 2019: the extramural LUMC academic network data infrastructure","volume":"132","author":"Ardesch","year":"2023","journal-title":"Health Policy"},{"key":"2025103018251533000_75.760.e749.22","unstructured":"NHG werkgroep (2023) [National Dutch General Practitioners Association. Guidelines for the treatment of diabetes]. [Article in Dutch]. accessed. https:\/\/richtlijnen.nhg.org\/standaarden\/diabetes-mellitus-type-2. 3 Oct 2025."},{"key":"2025103018251533000_75.760.e749.23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fendo.2019.00045","article-title":"Diabetes and aging: from treatment goals to pharmacologic therapy","volume":"10","author":"Longo","year":"2019","journal-title":"Front Endocrinol"},{"key":"2025103018251533000_75.760.e749.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05891-x"},{"key":"2025103018251533000_75.760.e749.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0903-2"},{"key":"2025103018251533000_75.760.e749.26","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S275898"},{"key":"2025103018251533000_75.760.e749.27","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.92.7.1151"},{"key":"2025103018251533000_75.760.e749.28","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.329"},{"key":"2025103018251533000_75.760.e749.29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-57"},{"key":"2025103018251533000_75.760.e749.30","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2890"},{"issue":"2","key":"2025103018251533000_75.760.e749.31","first-page":"67","article-title":"Investigating maturity onset diabetes of the young","volume":"30","author":"Nyunt","year":"2009","journal-title":"Clin Biochem Rev"},{"key":"2025103018251533000_75.760.e749.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01556.x"},{"issue":"4","key":"2025103018251533000_75.760.e749.33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jdiacomp.2006.12.001","article-title":"Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK","volume":"22","author":"Yurgin","year":"2008","journal-title":"J Diabetes Complications"},{"key":"2025103018251533000_75.760.e749.34","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13009"},{"issue":"8","key":"2025103018251533000_75.760.e749.35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s13300-020-00855-5","article-title":"Rationale for timely insulin therapy in type 2 diabetes within the framework of individualised treatment: 2020 update","volume":"11","author":"Hanefeld","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025103018251533000_75.760.e749.36","first-page":"S8","article-title":"1. Improving care and promoting health in populations: standards of medical care in diabetes \u2014 2022","volume":"45 (Suppl 1)","year":"2022","journal-title":"Diabetes Care"},{"key":"2025103018251533000_75.760.e749.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03694.x"},{"key":"2025103018251533000_75.760.e749.38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/DMSO.S331654","article-title":"Personalized type 2 diabetes management: an update on recent advances and recommendations","volume":"15","author":"Williams","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025103018251533000_75.760.e749.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00802.x"},{"issue":"2","key":"2025103018251533000_75.760.e749.40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-020-05319-w","article-title":"Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses","volume":"64","author":"Nanayakkara","year":"2021","journal-title":"Diabetologia"},{"issue":"10","key":"2025103018251533000_75.760.e749.41","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1172\/JCI129188","article-title":"\u03b2 cell dysfunction during progression of metabolic syndrome to type 2 diabetes","volume":"129","author":"Hudish","year":"2019","journal-title":"J Clin Invest"},{"issue":"7","key":"2025103018251533000_75.760.e749.42","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac046","article-title":"\u03b2-cell dynamics in type 2 diabetes and in dietary and exercise interventions","volume":"14","author":"Lv","year":"2022","journal-title":"J Mol Cell Biol"},{"key":"2025103018251533000_75.760.e749.43","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300423"},{"issue":"1","key":"2025103018251533000_75.760.e749.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-019-4557-4","article-title":"Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice","volume":"19","author":"Tran","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2025103018251533000_75.760.e749.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000186"},{"key":"2025103018251533000_75.760.e749.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2021.02.008"},{"issue":"6","key":"2025103018251533000_75.760.e749.47","first-page":"1390","article-title":"Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development","volume":"10","author":"Konstantinou","year":"2020","journal-title":"Transl Behav Med"},{"key":"2025103018251533000_75.760.e749.48","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-9-200111060-00012"},{"key":"2025103018251533000_75.760.e749.49","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0053"},{"key":"2025103018251533000_75.760.e749.50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083292"},{"key":"2025103018251533000_75.760.e749.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01614.x"},{"key":"2025103018251533000_75.760.e749.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2009.11.006"},{"issue":"1","key":"2025103018251533000_75.760.e749.53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/liv.14650","article-title":"A tool to predict progression of non\u2010alcoholic fatty liver disease in severely obese patients","volume":"41","author":"Bauvin","year":"2021","journal-title":"Liver Int"},{"key":"2025103018251533000_75.760.e749.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-2014-9","article-title":"Impact of socioeconomic status and subjective social class on overall and health-related quality of life","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Public Health"},{"key":"2025103018251533000_75.760.e749.55","doi-asserted-by":"publisher","DOI":"10.1186\/1475-9276-13-43"},{"key":"2025103018251533000_75.760.e749.56","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2017.0102"},{"key":"2025103018251533000_75.760.e749.57","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318249c949"},{"key":"2025103018251533000_75.760.e749.58","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0340-z"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2024.0693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:41:31Z","timestamp":1765370491000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2024.0693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":58,"journal-issue":{"issue":"760","published-online":{"date-parts":[[2025,10,30]]},"published-print":{"date-parts":[[2025,11,1]]}},"alternative-id":["10.3399\/BJGP.2024.0693"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2024.0693","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"type":"print","value":"0960-1643"},{"type":"electronic","value":"1478-5242"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}